StructureChemical NameCASMF
(R)-2-HYDROXYBUTYRIC ACID C4H8O3
22(R)-hydroxydesmosterol 54604-98-7 C27H44O2
(4R)-4-(2-HYDROXYETHYL)-2-PHENYL-1,3-DIOXOLANE 187102-96-1 C11H14O3
20R-INOKOSTERONE C27H44O7
rHyFilaggrin
Rin protein (GTPase)
RIOHAIRNATURALIZERSYSTEM
RIN1(RASINHIBITOR),~100KDAND35KD,GOATANTI-HUMAN:WB
RIP 228544-21-6 C45H55N9O12
RINSE SOLUTION
RIPA Buffer Concentrate
RIPA BUFFER
RINT-1 protein, human
Ripaglinide
riparin 112356-54-4 C16H17NO4
RI PBLUESCRIPT(R) II RI PREDIGESTED VECTORS
Ripazepam 26308-28-1 C15H16N4O
rhynchonin B
rhynchotechol 133086-78-9 C17H14O6
rhynchonin A
Rhynchophylline 76-66-4 C22H28N2O4
R-(+)-Hyoscyamine 13269-35-7 C17H23NO3
RIPE SWEET TOMATO
RIOPROSTIL 77287-05-9 C21H38O4
RIPIDOLITE
Riot Control Agents, Chemical
Ripinirole HCL
Ripisartan 148504-51-2 C23H22N8O
Rip1 peroxidase
ripostatin A
ripostatin B 157676-95-4 C30H40O6
Ripple filler
RIP60 protein
RIP1 protein, yeast
RIP2 protein
RIP3(RECEPTORINTERACTINGPROTEIN3),RABBITANTI-MOUSE,RAT:WB
Rir1a protein
RK-397 154396-73-3 C35H56O10
RK-682 154639-24-4 C21H36O5
RisA protein
RISBZ1 protein
Risedremate Sodium 329003-65-8 C7H14NNaO8P2
Risedronic Acid Monoethyl Ester 1246815-73-5 C9H15NO7P2
Risedronate Related Compound B (20 mg) ([3,6-bis[(3-pyridinyl)methyl]-2,5-dihydroxy-2,5-dioxido-1,4,2,5-dioxadiphosphorinane-3,6-diyl]bis[phosphonic acid] disodium tetrahydrate salt)
RISEDRONIC ACID-D4 C7H7D4NO7P2
Risedronic acid 105462-24-6 C7H11NO7P2
RisedronateSodium[1-Hydroxy-2-(3-Pyrikdinyl)Ethyudene]BisphosPhonicAcid
Risedronate Sodium Monohydrate
Risedronate Acid
Risedronic Acid-d6
Risedronic Acid-d4 (major) C7H11NO7P2
Sodium risedronate 115436-72-1 C7H12NNaO7P2
RISDRONATE SODIUM C7H10NNaO7P2
(-)-Rishitin 18178-54-6 C14H22O2
Rishitinol 31316-42-4 C15H22O2
Rishitin 59545-99-2 C14H22O2
rishirilide A 93361-65-0 C21H24O7
Rising and falling film absorber
Rising-falling film evaporator
RISK-1
RISKASSESSMENTOFCARCINOGENICITY
RISKASSESSMENT(CONTACTDERMATITIS)
RISKASSESSMENTFORCHILDREN
RISKASSESSMENTFORELDERLY
RISKASSESSMENT
RISKANALYSIS
RISKASSESSMENT(NUTRIENTS)
RISKASSESSMENT(GENERAL)
RISKASSESSMENTOFCARCINOGENS
RISKBENEFITANALYSIS
RitaExtract
Ritalinic Acid-d10 Discontinued C13H7D10NO2
Ritalinic-d9 Acid HCl
Ritalinic acid 19395-41-6 C13H17NO2
Ritalinic Acid-d10 C13H17NO2
Ritalinic Acid-d10 Hydrochloride Salt C13H8D10ClNO2
Ritalin 113-45-1 C14H19NO2
RISKMANAGEMENT
Ritanserin 87051-43-2 C27H25F2N3OS
RITANSERIN, FREE BASE OR L-TARTRATE SALT
RITA protein
RISKRANKING
RISKREDUCTION
Rita/SoapNut
RITC-DEXTRAN
RIT-CIZER NO 9
Rismorelin
R-2-ISOBUTYL-PIPERAZINE-2HCl 853730-57-1 C8H18N2
R-2-Isobutyl-1,2,3,4-tetrahydro-quinoline 1115387-00-2 C13H19N
R-Isobutyl-D-cysteine C7H15NO2S
[R,(+)]-3-Isobutyl-5-methyl-2,3-hexanediol C11H24O2
R-4-Isobutyl-2-Oxazolidone C7H13NO2
(R)-3-Isobutylmorpholine 711014-40-3 C8H17NO
(R)-(-)-2-isobutylsuccinic acid 4-methyl ester C9H16O4
(R)-4-ISOBUTYL-2-OXAZOLIDINONE C7H13NO2
(R)-1-(4-ISOBUTYLPHENYL)ETHANAMINE 1212142-57-8 C12H19N
(R)-4-ISOBUTYL-OXAZOLIDINE-2,5-DIONE 51018-87-2 C7H11NO3
(R)-6-ISOBUTYL-PIPERAZIN-2-ONE C8H16N2O
(R)-3-ISOBUTYL-PIPERAZIN-2-ONE C8H16N2O
(4R)-4-Isobutyl-2-oxazolidinone 161106-42-9 C7H13NO2
220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380